Does the media prefer OMCL or SENS?

In the previous week, Omnicell had 4 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 7 mentions for Omnicell and 3 mentions for Senseonics Holdings, Inc. Common Stock. Omnicell's average media sentiment score of 1.14 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that Omnicell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Senseonics Holdings, Inc. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SENS or ATEC?

In the previous week, Alphatec had 8 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 11 mentions for Alphatec and 3 mentions for Senseonics Holdings, Inc. Common Stock. Alphatec's average media sentiment score of 1.06 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senseonics Holdings, Inc. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SENS or CNMD?

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than CONMED. MarketBeat recorded 3 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for CONMED. CONMED's average media sentiment score of 1.34 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senseonics Holdings, Inc. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

$9.06 +0.18 (+2.03%)

Closing price 04:00 PM Eastern

Extended Trading

$9.14 +0.07 (+0.83%)

As of 07:30 PM Eastern

Compare

SENS vs. OMCL, KMTS, ATEC, CNMD, and TNDM

Should you buy Senseonics Holdings, Inc. Common Stock stock or one of its competitors? Senseonics Holdings, Inc. Common Stock's main competitors and comparable companies include Omnicell (OMCL), Kestra Medical Technologies (KMTS), Alphatec (ATEC), CONMED (CNMD), and Tandem Diabetes Care (TNDM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Senseonics Holdings, Inc. Common Stock compare to Omnicell?

Omnicell (NASDAQ:OMCL) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Omnicell presently has a consensus target price of $57.86, indicating a potential upside of 78.41%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, indicating a potential upside of 89.85%. Given Senseonics Holdings, Inc. Common Stock's higher possible upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Omnicell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Omnicell has a net margin of 3.13% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Omnicell's return on equity of 5.66% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	3.13%	5.66%	3.57%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

In the previous week, Omnicell had 4 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 7 mentions for Omnicell and 3 mentions for Senseonics Holdings, Inc. Common Stock. Omnicell's average media sentiment score of 1.14 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Omnicell has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.18B	1.24	$2.05M	$0.84	38.61
Senseonics Holdings, Inc. Common Stock	$35.26M	10.74	-$69.11M	-$2.23	N/A

97.7% of Omnicell shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 2.9% of Omnicell shares are held by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Omnicell has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

Summary

Omnicell beats Senseonics Holdings, Inc. Common Stock on 12 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Kestra Medical Technologies?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.20, suggesting a potential upside of 89.85%. Kestra Medical Technologies has a consensus target price of $28.38, suggesting a potential upside of 17.84%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, research analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Senseonics Holdings, Inc. Common Stock has higher earnings, but lower revenue than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	10.74	-$69.11M	-$2.23	N/A
Kestra Medical Technologies	$95.13M	14.83	-$131.61M	-$2.42	N/A

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Senseonics Holdings, Inc. Common Stock has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

Kestra Medical Technologies has a net margin of -140.43% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Kestra Medical Technologies' return on equity of -62.82% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
Kestra Medical Technologies	-140.43%	-62.82%	-45.42%

In the previous week, Kestra Medical Technologies had 28 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 3 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.63 beat Kestra Medical Technologies' score of 0.04 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	7 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Senseonics Holdings, Inc. Common Stock beats Kestra Medical Technologies on 8 of the 15 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Alphatec?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 13.5% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.20, indicating a potential upside of 89.85%. Alphatec has a consensus target price of $17.40, indicating a potential upside of 65.71%. Given Senseonics Holdings, Inc. Common Stock's higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Alphatec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Senseonics Holdings, Inc. Common Stock has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	10.74	-$69.11M	-$2.23	N/A
Alphatec	$764.16M	2.12	-$143.36M	-$0.71	N/A

Senseonics Holdings, Inc. Common Stock has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

In the previous week, Alphatec had 8 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 11 mentions for Alphatec and 3 mentions for Senseonics Holdings, Inc. Common Stock. Alphatec's average media sentiment score of 1.06 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alphatec has a net margin of -13.49% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Senseonics Holdings, Inc. Common Stock's return on equity of -165.80% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
Alphatec	-13.49%	-6,752.24%	-13.88%

Summary

Alphatec beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to CONMED?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and CONMED (NYSE:CNMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than CONMED. MarketBeat recorded 3 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for CONMED. CONMED's average media sentiment score of 1.34 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Senseonics Holdings, Inc. Common Stock has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, CONMED has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

Senseonics Holdings, Inc. Common Stock presently has a consensus price target of $17.20, indicating a potential upside of 89.85%. CONMED has a consensus price target of $41.40, indicating a potential downside of 12.10%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, research analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

CONMED has a net margin of 4.12% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. CONMED's return on equity of 14.31% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
CONMED	4.12%	14.31%	6.33%

CONMED has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	10.74	-$69.11M	-$2.23	N/A
CONMED	$1.37B	1.03	$47.06M	$1.85	25.46

Summary

Senseonics Holdings, Inc. Common Stock and CONMED tied by winning 8 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Tandem Diabetes Care?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 2.1% of Tandem Diabetes Care shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Tandem Diabetes Care has a net margin of -6.08% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Tandem Diabetes Care's return on equity of -45.97% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
Tandem Diabetes Care	-6.08%	-45.97%	-6.23%

Senseonics Holdings, Inc. Common Stock has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	10.74	-$69.11M	-$2.23	N/A
Tandem Diabetes Care	$1.01B	1.20	-$204.71M	-$0.93	N/A

Senseonics Holdings, Inc. Common Stock has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Tandem Diabetes Care has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market.

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.20, suggesting a potential upside of 89.85%. Tandem Diabetes Care has a consensus target price of $29.34, suggesting a potential upside of 67.38%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, equities research analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.48

In the previous week, Tandem Diabetes Care had 3 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 6 mentions for Tandem Diabetes Care and 3 mentions for Senseonics Holdings, Inc. Common Stock. Tandem Diabetes Care's average media sentiment score of 1.56 beat Senseonics Holdings, Inc. Common Stock's score of 0.63 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tandem Diabetes Care	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Tandem Diabetes Care beats Senseonics Holdings, Inc. Common Stock on 10 of the 17 factors compared between the two stocks.

Get Senseonics Holdings, Inc. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SENS vs. The Competition

Export

Metric	Senseonics Holdings, Inc. Common Stock	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$378.71M	$5.49B	$7.19B	$14.92B
Dividend Yield	N/A	1.79%	2.57%	11.71%
P/E Ratio	-4.06	25.26	274.09	25.35
Price / Sales	10.74	68.32	697.83	112.39
Price / Cash	N/A	32.78	77.71	51.48
Price / Book	6.08	5.96	10.37	6.25
Net Income	-$69.11M	$151.55M	$3.49B	$358.55M
7 Day Performance	3.90%	-1.60%	-1.78%	-2.07%
1 Month Performance	16.01%	-4.12%	-1.48%	-4.80%
1 Year Performance	N/A	8.63%	18.20%	5.44%

Senseonics Holdings, Inc. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SENS Senseonics Holdings, Inc. Common Stock	3.4883 of 5 stars	$9.06 +2.0%	$17.20 +89.8%	N/A	$378.71M	$35.26M	N/A	130
OMCL Omnicell	4.3824 of 5 stars	$33.64 -0.7%	$57.86 +72.0%	+1.1%	$1.54B	$1.18B	40.05	3,580	Positive News
KMTS Kestra Medical Technologies	1.9628 of 5 stars	$24.07 -6.1%	$28.14 +16.9%	+11.0%	$1.50B	$95.13M	N/A	300	Trending News Earnings Report Analyst Forecast
ATEC Alphatec	4.1847 of 5 stars	$8.98 -2.3%	$17.40 +93.8%	-29.2%	$1.42B	$764.16M	N/A	700	Positive News High Trading Volume
CNMD CONMED	1.7067 of 5 stars	$47.09 +1.1%	$41.40 -12.1%	-9.5%	$1.40B	$1.37B	25.45	3,900	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SENS) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

SENS vs. OMCL, KMTS, ATEC, CNMD, and TNDM

How does Senseonics Holdings, Inc. Common Stock compare to Omnicell?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Kestra Medical Technologies?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Alphatec?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to CONMED?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Tandem Diabetes Care?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SENS vs. The Competition

Senseonics Holdings, Inc. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

SENS vs. OMCL, KMTS, ATEC, CNMD, and TNDM

How does Senseonics Holdings, Inc. Common Stock compare to Omnicell?

Do analysts rate OMCL or SENS?

Is OMCL or SENS more profitable?

Does the media prefer OMCL or SENS?

Which has higher earnings and valuation, OMCL or SENS?

Do insiders and institutionals hold more shares of OMCL or SENS?

Which has more risk & volatility, OMCL or SENS?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Kestra Medical Technologies?

Do analysts rate SENS or KMTS?

Which has preferable earnings & valuation, SENS or KMTS?

Do insiders and institutionals hold more shares of SENS or KMTS?

Which has more volatility and risk, SENS or KMTS?

Is SENS or KMTS more profitable?

Does the media refer more to SENS or KMTS?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Alphatec?

Do insiders & institutionals believe in SENS or ATEC?

Do analysts recommend SENS or ATEC?

Which has better valuation & earnings, SENS or ATEC?

Which has more risk & volatility, SENS or ATEC?

Does the media favor SENS or ATEC?

Is SENS or ATEC more profitable?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to CONMED?

Do institutionals and insiders hold more shares of SENS or CNMD?

Does the media favor SENS or CNMD?

Which has more risk & volatility, SENS or CNMD?

Do analysts prefer SENS or CNMD?

Is SENS or CNMD more profitable?

Which has higher valuation and earnings, SENS or CNMD?

Summary

How does Senseonics Holdings, Inc. Common Stock compare to Tandem Diabetes Care?

Do institutionals & insiders hold more shares of SENS or TNDM?

Is SENS or TNDM more profitable?

Which has preferable valuation & earnings, SENS or TNDM?

Which has more volatility & risk, SENS or TNDM?

Do analysts rate SENS or TNDM?

Does the media favor SENS or TNDM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SENS vs. The Competition

Senseonics Holdings, Inc. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools